![]() Simon Deycmar, PhD Brendan Johnson, DVM Declan Ryan William S. Molecular characterization of naturally occurring colorectal and breast cancer in non-human primates to model human immunotherapeutic agents HarunaĪdoptive immunotherapy Antibody B cell Biomarkers Dendritic cell Immune toxicity T cell Tertiary lymphoid structure in pancreatic ductal adenocarcinoma a potential target in an immunologically inert malignancy Paulos, PhDĬhemokine Cytokine Solid tumors T cell Tumor infiltrating lymphocytes (TILs) Christina Pitzka Daniela Rheindorf Nadine Mockel-Tenbrinck Tatjana Holzer, PhD Anne Richter, PhD Toni Cathomen, PhD Cesar Evaristo, PhDĪdoptive immunotherapy Biomarkers CAR T cells Costimulation COVID and Immunotherapy Immune monitoring Immune tolerance Leukemia/Lymphoma Tumor evasion Tumor microenvironmentīRaf mutations are associated with T-helper cell infiltration and polarization in melanoma Multiparameter characterization of CAR T cells Shanthy Nuti, PhD Kenneth Emancipator, MDīiomarkers Checkpoint blockade Solid tumors Vainer Ghadeer Zatara Lingkang Huang, Ph.D. Gulley, MD, PhD Jeffrey Schlom, PhDĪntibody Biomarkers Bispecifics Checkpoint blockade Clinical study Clinical trial Immune monitoring Solid tumors T cell Targeted therapyĪnalytical comparison of a PD-L1 22C3 antibody laboratory-developed test protocol on the Benchmark XT and PD-L1 IHC 22C3 pharmDx: pan-tumor and triple-negative breast cancer samples Immune correlates of clinical benefit in patients with HPV-associated malignancies treated with bintrafusp alfa ![]() Seitz Gregory Vidal, MD PhDīioinformatics Biomarkers Clinical study Gene expression RNA Targeted therapy Tumor infiltrating lymphocytes (TILs) Tumor microenvironment Tumor stroma Schreiber, MD, PhDģD Coculture platform reveals insights into patient autologous immune cell-tumor interaction and immune modulation in vitroĬheckpoint blockade Cytokine Immune monitoring Regulatory T cell (Treg cell) Solid tumors T cell T cell lineages Tumor evasion Tumor infiltrating lymphocytes (TILs) Tumor microenvironmentĬD274 (PD-L1) gene expression and the 27-gene immuno-oncology (IO) assay are associated with efficacy to immune checkpoint inhibitor treated patients with non-small cell lung cancer (NSCLC). Gonzalez, PhD Bo Ma, PhD Robert Hernandez, PhD Hannah McKay Fatima Rangwala, MD, PhD Lini Pandite, MD Taylor H. ![]() Blakemoreīiomarkers Bispecifics Costimulation Gene expression Immune contexture Immune monitoring Solid tumors T cell Targeted therapy Tumor microenvironmentĭevelopment of an integrated method to quantify receptor occupancy for agonist immunotherapeutics that stimulate target cells to migrate from the peripheral blood Parnell, PhD Phil Brandish Sebastien Hazard Dominic Smethurst Nicholas Keen Stephen J. Heather Cohen Carly Campbell Kristen Hurov Johanna Lahdenranta Tara Gelb David Galbraith Dan Rozelle Mate L. Quantitation of CD137 and Nectin-4 expression across multiple tumor types to support indication selection for BT7480, a Bicycle tumor-targeted immune cell agonist™ (Bicycle TICA™) Laura Bergamaschi Federica Perrone Francesca Rini Licia Rivoltini Chiara Castelli, PhD Alessandro Gronchi Chiara Colombo Viviana Vallacchiīiomarkers, Immune Monitoring, and Novel Technologies 9, 2022.ĭissecting β-catenin associated inflammation in patients with desmoid fibromatosis to identify prognostic biomarkers 12, 2021 until the virtual meeting platform is closed on Jan. ePostersĮPosters will be on display on the SITC 2021 virtual meeting platform from 7 a.m. Even numbered posters will be presented Saturday, Nov. All odd numbered posters will be presented on Friday, Nov. Washington Convention Center in Washington, D.C. Onsite posters will be presented in the Poster Hall at the Walter E. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |